← Back to Search

Lifestyle Changes for Gestational Diabetes (TLC Trial)

N/A
Recruiting
Led By Ebony B Carter, MD,MPH
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up delivery
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare the effects of Targeted Lifestyle Change Group Prenatal Care (TLC) versus usual care on maternal and neonatal outcomes in women at high risk for developing gestational diabetes mellitus (GDM).

Who is the study for?
This trial is for English-speaking women under 16 weeks pregnant, at high risk for gestational diabetes due to factors like being overweight, inactive, having a family history of diabetes or certain ethnic backgrounds. They must be able to attend group prenatal visits and agree to random assignment in the study.
What is being tested?
The study is testing Targeted Lifestyle Change Group Prenatal Care (TLC) to see if it improves outcomes for mothers and babies at risk of gestational diabetes. Women will be randomly placed into groups where they receive this specialized care during pregnancy.
What are the potential side effects?
Since TLC involves lifestyle changes rather than medication, side effects are minimal but may include the discomforts typically associated with changes in diet and exercise routines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and delivery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Effects of TLC group prenatal care on birth weight
Total Lung Capacity
Effects of TLC group prenatal care on neonatal length
+1 more
Secondary study objectives
Assessing prenatal care patient satisfaction for those in TLC compared to traditional prenatal care using a satisfaction survey.
Breastfeeding rates among those in TLC compared to traditional prenatal care.
Depression
+30 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TLC Group Prenatal CareExperimental Treatment1 Intervention
TLC will start in the late first trimester or early second trimester and run for \~6-10 sessions. Groups of 2-10 consented women, with two or more GDM risk factors, will meet under the supervision of an obstetric provider (nurse practitioner or MD) and co-facilitator (health educator, nutritionist, or nurse) for two-hour sessions. A major focus of TLC will be education, and much of each visit will be spent on pregnancy, exercise/nutrition education, and behavioral health.
Group II: Traditional Prenatal CareActive Control1 Intervention
Subjects randomized to routine care will receive their prenatal care with their primary obstetric provider. Patients are seen for 10-15 minutes every four weeks until 28 weeks' gestation, every two weeks (or more by provider discretion) until 37 weeks and weekly until delivery. Visits focus on routine screening tests and prenatal care. Traditional care participants will receive a phone call once a month, until 28 weeks gestation, from a nurse practitioner to check-in on pregnancy goals, healthy eating, and exercise. Each subject's medical chart will be reviewed for demographics, antenatal management, maternal and neonatal outcomes.

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,557 Previous Clinical Trials
4,298,493 Total Patients Enrolled
American Diabetes AssociationOTHER
143 Previous Clinical Trials
100,662 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
1,991 Previous Clinical Trials
2,295,444 Total Patients Enrolled

Media Library

TLC Group Prenatal Care Clinical Trial Eligibility Overview. Trial Name: NCT04090307 — N/A
Gestational Diabetes Research Study Groups: Traditional Prenatal Care, TLC Group Prenatal Care
Gestational Diabetes Clinical Trial 2023: TLC Group Prenatal Care Highlights & Side Effects. Trial Name: NCT04090307 — N/A
TLC Group Prenatal Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04090307 — N/A
~69 spots leftby Dec 2025